Human CD19+CD25high B regulatory cells suppress proliferation of CD4+ T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cellsAharon Kessel, Elias Toubi, Tharwat Haj et al.|Autoimmunity Reviews|2011Cited by 293
Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy.Ayelet Snir, Elias Toubi, Aharon Kessel et al.|PubMed|2011Cited by 48
IVIg Attenuates TLR-9 Activation in B Cells from SLE PatientsAharon Kessel, Elias Toubi, Gleb Slobodin et al.|Journal of Clinical Immunology|2010Cited by 45
Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapyAyelet Snir, Elias Toubi, Aharon Kessel et al.|Annals of the Rheumatic Diseases|2011Cited by 37
B Cell‐Activating Factor Enhances Interleukin‐6 and Interleukin‐10 Production by ODN‐Activated Human B CellsDana Yehudai, Aharon Kessel, Ayelet Snir et al.|Scandinavian Journal of Immunology|2012Cited by 27